Lipid Metabolism Disorders

Actionable Insights Powered by AI

Rona’s Sanofi-Sourced siRNA Demonstrates Early Efficacy in Dyslipidaemia Treatment

siRNA, dyslipidaemia, Rona, Sanofi, RNA interference, lipid disorders, therapeutic development